A

Andrew M. Scott

Olivia Newton-John Cancer Wellness & Research Centre

ORCID: 0000-0002-6656-295X

1.2k papers and 37.1k citations.

PubIndex Score98Top 2%How it's scored

1.2kPublications

37.1kTotal Citations

First publication: 1964First senior author: 1952

Top publicationsby citations

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans

Ian D. Davis, Jonathan Cebon, Simon Green et al.|Proceedings of the National Academy of Sciences|2004

Cited by 440

Antibody–Drug Conjugates for Cancer Therapy

Umbreen Hafeez, Andrew M. Scott|Molecules|2020

Cited by 377

FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy

Jack D. Chan, Phillip K. Darcy, C. Scheffler et al.|Nature|2024

Cited by 213

Identification of the Epitope for the Epidermal Growth Factor Receptor-specific Monoclonal Antibody 806 Reveals That It Preferentially Recognizes an Untethered Form of the Receptor

Terrance G. Johns, Andrew M. Scott|Journal of Biological Chemistry|2004

Cited by 145

Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen

Stefan Peinert, Dirk Hönemann, H. Miles Prince et al.|Gene Therapy|2010

Cited by 118

Indexing the rest of 1,206 publications…